GlassScriptPhysician profile
Shifra Baum
NPI 1326590878
$1,175.46
in general payments reported to CMS, 2019-2025
11 companies · $40.76 in 2025
The $40.76 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $108 · 2023: $569 · 2024: $458 · 2025: $40.76.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,067.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,067.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $333.92 | 2022-2023 | Gore Viabahn Endoprosthesis |
| Atricure, INC. | $200.39 | 2024 | |
| E.R. Squibb & Sons, L.L.C. | $150.00 | 2023 | |
| Abbvie INC. | $121.41 | 2022-2025 | |
| Janssen Biotech, INC. | $112.50 | 2024 | Stelara, Tremfya |
| Astrazeneca Pharmaceuticals LP | $93.91 | 2023 | Breztri |
| Gilead Sciences, INC. | $42.22 | 2022-2025 | |
| Ethicon US, LLC | $37.72 | 2024 | Ethicon, Enseal |
| Takeda Pharmaceuticals U.S.A., INC. | $32.13 | 2024 | Entyvio |
| Orphalan INC | $30.80 | 2024 | Cuvrior |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.46 | 2023 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shifra Baum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.